secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K/A
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001062993-25-012533
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma signs share exchange agreement to acquire Antev Limited
----------------------------------------------------------------------

- Agreement to acquire all Antev Shares; Antev becomes wholly-owned subsidiary of Medicus.
- Consideration includes Purchaser Shares (Consideration Shares) and Contingent Consideration tied to milestones.
- Antev's lead candidate Teverelix (for acute urinary retention) referenced in forward-looking statements.
- Closing expected 3 Business Days after conditions satisfied; drag-along provisions apply for all shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325012533/0001062993-25-012533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325012533/form8ka.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-012533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer